Literature DB >> 10065149

Mechanisms of p53-mediated apoptosis.

S Bates1, K H Vousden.   

Abstract

The loss of p53-mediated apoptosis (programmed cell death) has been implicated as an important event in tumour progression in a number of systems. p53 can induce or potentiate apoptosis through several mechanisms, both by regulating the expression of genes which can participate in the apoptotic response and through transcriptionally independent means. There appears to be cell type variability in both the response to p53 expression and in the requirement for p53 transcriptional transactivation for the induction of apoptosis. It seems clear, however, that the induction of p53 in untransformed cells is more likely to result in cell-cycle arrest, whereas the expression of p53 in their transformed counterparts is more likely to result in the induction of apoptosis, and this may, in part, reflect the deregulated expression of E2F-1 in tumour cells. The synergistic action of p53 and E2F-1 in the induction of apoptosis has raised the possibility that the reactivation of p53 in transformed cells can be an effective tumour therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065149     DOI: 10.1007/s000180050267

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  58 in total

1.  Identification and classification of p53-regulated genes.

Authors:  J Yu; L Zhang; P M Hwang; C Rago; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase.

Authors:  Fei Su; Michael Overholtzer; Daniel Besser; Arnold J Levine
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

4.  Regulation of ultraviolet light-induced gene expression by gene size.

Authors:  Bruce C McKay; Lawton J Stubbert; Casey C Fowler; Jennifer M Smith; Robin A Cardamore; Jennifer C Spronck
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

5.  Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL.

Authors:  S B Gibson; R Oyer; A C Spalding; S M Anderson; G L Johnson
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  Cloning and characterization of the human gene DERP6, which activates transcriptional activities of p53.

Authors:  Jian Yuan; Wenwen Tang; Kuntian Luo; Xinya Chen; Xiuting Gu; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2006-09       Impact factor: 2.316

7.  UV-Induced stabilization of c-fos and other short-lived mRNAs.

Authors:  C Blattner; P Kannouche; M Litfin; K Bender; H J Rahmsdorf; J F Angulo; P Herrlich
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.

Authors:  An-Chi Tsai; Shiow-Lin Pan; Hui-Lung Sun; Chih-Ya Wang; Chieh-Yu Peng; Shih-Wei Wang; Ya-Ling Chang; Sheng-Chu Kuo; Kuo-Hsiung Lee; Che-Ming Teng
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

9.  Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Free Radic Biol Med       Date:  2008-02-26       Impact factor: 7.376

10.  Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer.

Authors:  Shin-ichi Yamashita; Masao Chujo; Michiyo Miyawaki; Keita Tokuishi; Kentaro Anami; Satoshi Yamamoto; Katsunobu Kawahara
Journal:  J Exp Clin Cancer Res       Date:  2009-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.